secwatch / observer
8-K filed November 25, 2024, 6:59 PM ET ticker BCTX CIK 0001610820
leadership confidence high sentiment neutral materiality 0.30

Director Marc Lustig resigns from BriaCell Therapeutics board

BriaCell Therapeutics Corp.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Marc Lustig

director
BCTX · BriaCell Therapeutics Corp.
Effective
2024-11-23
Filed
November 25, 2024, 6:59 PM ET
On November 23, 2024, Marc Lustig resigned from the board of directors of BriaCell Therapeutics Corp. (the “Company”)

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marc Lustig resigned as director at BriaCell Therapeutics Corp..

Action
resigned
Role
director
Exact text from the filing
On November 23, 2024, Marc Lustig resigned from the board of directors of BriaCell Therapeutics Corp. (the “Company”)
View on SEC.gov

BriaCell Therapeutics Corp. filing history →

Source: SEC EDGAR
accession 0001493152-24-047606
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.